Moving Beyond Convention: Managing Thyroid Eye Disease

0.50 CME
0.50 CME WITH ABO CONTINUING CERTIFICATION
30 MINS
$0 FEE
SAVE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Faculty Photo

Overview

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education


Support Statement

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.


Activity Description

Thyroid eye disease (TED) is an autoimmune disease that is believed to result from the stimulation of several receptors located in the orbital fibroblasts. It is frequently misdiagnosed, due to both the heterogeneity of clinical presentation and a failure to understand the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at risk, as management is most effective during the initial active phase of the disease. However, differential diagnosis can be achieved with the assistance of imaging, and early treatment may limit disfigurement and reduce vision loss. Ophthalmologists should be knowledgeable about the conventional and new treatments available for the treatment of TED and how to apply this information into practice. In this CME activity, experts in the field will explore conventional and new treatment options for patients with TED, including teprotumumab, the first and only medical agent approved by the US Food and Drug Administration for the treatment of TED.


Target Audience

The intended audience for this activity is comprehensive ophthalmologists and other health care professionals involved in the management of patients with thyroid eye disease.


Learning Objectives

Upon successful completion of this activity, participants should be better able to:

  • Assess evidence-based criteria and best practices that can improve the differential diagnosis of thyroid eye disease.
  • Evaluate the safety and efficacy of conventional and new treatments for the management of patients with thyroid eye disease.

Activity Chair

Wendy W. Lee, MD
Professor of Clinical Ophthalmology and Dermatology
Director, Bascom Palmer Aesthetics Center
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL


Faculty

Roger A. Dailey, MD, FACS
Lester T. Jones Endowed Chair
Division of Oculofacial Plastic & Reconstructive Surgery
Chief, Casey Aesthetic Facial Surgery Center
Former President of the American Society of Ophthalmic Plastic & Reconstructive Surgery (ASOPRS)
Portland, OR


Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning and Self-Assessment requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting credit.

Upon successful completion, learners who opt-in by providing their ABO ID and DOB (MM/DD) will earn credits equivalent to the amount of CME credits claimed for the activity.

This enduring material is approved for 1 year from the date of original release, July 20, 2021, to July 19, 2022.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of 3 posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all accredited providers are required to mitigate and disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of accredited content. Individuals have a relevant financial relationship if they have a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the accredited activity content over which the individual has control. Relationship information appears below.  

Activity Chair and Faculty report the following relationship(s)

Wendy W. Lee, MD
Consulting Fee:Allergan, Galderma, Horizon, Mallinckrodt, Osmotica, Revance, Solta

Roger A. Dailey, MD, FACS
Consulting Fee: Horizon

Reviewer reports the following relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com